LAUREN FUSARO: Open Payments
NPI 1366987307 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$81 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $287 · 2025 $81
Food & beverage: $81
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| ABBVIE INC. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: REXULTI, CAPLYTA, VRAYLAR, TRINTELLIX.
Industry payments across PA — which companies pay providers there.
